A biopharmaceutical company that discovers and develops RNA interference (RNAi)-based cancer drugs using its proprietary LODER delivery platform to treat malignant solid tumors, including pancreatic cancer, prostate cancer, and glioblastoma.
Jerusalem, Israel~13 employeesFounded Jan 2008Website